Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Bitcoin Well (V.BTCW) Reports Q1 2024 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioCryst Pharmaceuticals Inc BCRX

Healthcare Biotechnology
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of... see more

Recent & Breaking News (NDAQ:BCRX)

BioCryst Pharmaceuticals Completes Peramivir Type C Meeting

Business Wire April 16, 2013

Major Indexes End Winning Streak and J.C. Penney to Start Selling Martha Stewart Goods

PR Newswire April 15, 2013

Free Research Reports on BCRX, CLNT, HMY and RATE Issued by the Paragon Report

Marketwired April 15, 2013

Free Research Reports on AMD, BCRX, BSDM and MTG Issued by the Paragon Report

Marketwired April 9, 2013

Traders' Favorite: National Bank of Greece, EMC Corporation, BioCryst Pharmaceuticals

Accesswire April 8, 2013

Squawk Box Stocks Reports on: BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), NII Holdings Inc. (NASDAQ: NIHD), Exide Technologies. (NASDAQ: XIDE), EnergySolutions, Inc. (NYSE: ES)

Marketwired April 8, 2013

InvestorsGuru.com 40 Filtered Mid-Day Market Movers Recap

Investors Guru April 7, 2013

U.S. Manufacturing Activity Expanded More Slowly in March and eBay Gets New Price Target

PR Newswire April 2, 2013

Free Research Reports on BCRX, KWK, GST and TSLA Issued by the Bedford Report

Marketwired April 2, 2013

BioCryst Pharmaceuticals Provides Update Regarding Peramivir

Business Wire April 1, 2013

FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Marketwired March 15, 2013

BioCryst Reports Fourth Quarter and Full Year 2012 Financial Results

Business Wire February 19, 2013

KERX, KORS, GTE and BCRX - Pre-Market Briefing

Marketwired February 14, 2013

Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

Marketwired February 13, 2013

BioCryst to Announce Fourth Quarter & 2012 Financial Results on February 19, 2013

Business Wire February 5, 2013

Free Research Reports on BCRX, HALO, HOLX and TELK Issued by the Bedford Report

Marketwired January 14, 2013

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Marketwired January 14, 2013

The Real Story Behind HIMX, ELON, BCRX and APP

Marketwired January 3, 2013

Elite Traders Group Issues Watch Alert on Micro-Cap Stocks With Momentum

Marketwired January 2, 2013

BioCryst to Present at J.P. Morgan Healthcare Conference

Business Wire January 2, 2013